Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-28

Clinical Trial Update: Intravenous Nalbuphine for Prevention of Intrathecal Morphine-induced Nausea and Vomiting in Patients Undergoing Cesarean Section: A Double-blind, Randomized Controlled Trial. [NA]

View source ↗

Summary

A completed double-blind randomized trial evaluated intravenous nalbuphine for prevention of intrathecal morphine-induced nausea and vomiting in patients underg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nalbuphine (nalbuphine)

Snippet

Sponsor: Thammasat University | Conditions: Intrathecal Morphine, Caesarean Section | NA | Status: COMPLETED